Beta blocker use and ovarian cancer survival: A retrospective cohort study

被引:15
|
作者
Eskander, R. [1 ]
Bessonova, L. [1 ]
Chiu, C. [1 ]
Ward, K. [2 ]
Culver, H. [1 ]
Harrison, T. [2 ]
Randall, L. [1 ]
机构
[1] UCI Med Ctr, Orange, CA USA
[2] Kaiser Permanente, San Diego, CA USA
关键词
D O I
10.1016/j.ygyno.2012.07.059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S21 / S21
页数:1
相关论文
共 50 条
  • [1] Beta blocker use and ovarian cancer survival: A retrospective cohort study
    Eskander, R.
    Randall, L.
    Bessonova, L.
    Ward, K.
    Culver, H. Anton
    Harrison, T.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S111 - S111
  • [2] Beta-Blocker Use and Ovarian Cancer Survival as Determined by Electronic Medical Records
    Beeghly-Fadiel, Alicia
    Holman, Gwendolyn
    Stansel, Samantha P.
    Edwards, Gretchen
    Delahanty, Ryan J.
    Zheng, Wei
    Khabele, Dineo
    JOURNAL OF WOMENS HEALTH, 2014, 23 (10) : 852 - 852
  • [3] Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer
    Gonzalez, R.
    Gockley, A. A.
    Melamed, A.
    Sugrue, R.
    Clark, R. M.
    Del Carmen, M. G.
    Growdon, W.
    Berkowitz, R. S.
    Horowitz, N. S.
    Worley, M. J., Jr.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (03) : 700 - 705
  • [4] Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer
    Gonzalez, R.
    Gockley, A. A.
    Melamed, A.
    Clark, R. M.
    Schorge, J. O.
    del Carmen, M. G.
    Berkowitz, R. S.
    Horowitz, N. S.
    Muto, M. G.
    Worley, M. J., Jr.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 209 - 210
  • [5] Impact of beta blocker medication on survival outcome of ovarian cancer: A nationwide population-based cohort study.
    Park, Jeong-Yeol
    Baek, Min-Hyun
    Park, Young-Han
    Kim, Dae-Yeon
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study
    Udumyan, Ruzan
    Botteri, Edoardo
    Jerlstrom, Tomas
    Montgomery, Scott
    Smedby, Karin E.
    Fall, Katja
    ACTA ONCOLOGICA, 2022, 61 (08) : 922 - 930
  • [7] Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study
    Kirkegard, Jakob
    Cronin-Fenton, Deirdre
    Lund, Andrea
    Mortensen, Frank Viborg
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [8] Effect of Peri-Operative Selective and Nonselective Beta Blocker Use on Survival in Ovarian Cancer Patients
    Mattappally, Nidha
    Korets, Sharmilee
    Hughes, Sarah
    Zweizig, Susan
    Bradford, Leslie
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 14S - 14S
  • [9] Evaluation of antihypertensive medications use and survival in patients with ovarian cancer: a population-based retrospective cohort study
    Everatt, Ruta
    Kuzmickiene, Irena
    Brasiuniene, Birute
    Vincerzevskiene, Ieva
    Intaite, Birute
    Cicenas, Saulius
    Lisauskiene, Ingrida
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [10] Evaluation of antihypertensive medications use and survival in patients with ovarian cancer: a population-based retrospective cohort study
    Rūta Everatt
    Irena Kuzmickienė
    Birutė Brasiūnienė
    Ieva Vincerževskienė
    Birutė Intaitė
    Saulius Cicėnas
    Ingrida Lisauskienė
    BMC Women's Health, 24